TrueBlue (TBI) Reports In-Line Q2 EPS, Revenues In-Line; Offers 3Q EPS / Revenue Guidance Range Below Consensus
Get Alerts TBI Hot Sheet
Price: $9.59 -2.84%
EPS Growth %: +466.7%
Financial Fact:
Depreciation and amortization: 11.69M
Today's EPS Names:
FUSE, INM, TRI, More
EPS Growth %: +466.7%
Financial Fact:
Depreciation and amortization: 11.69M
Today's EPS Names:
FUSE, INM, TRI, More
Join SI Premium – FREE
TrueBlue (NYSE: TBI) reported Q2 EPS of $0.42, in-line with the analyst estimate of $0.42. Revenue for the quarter came in at $610 million versus the consensus estimate of $610.03 million.
GUIDANCE:
TrueBlue sees Q3 2017 EPS of $0.55-$0.60, versus the consensus of $0.65. TrueBlue sees Q3 2017 revenue of $645-660 million, versus the consensus of $661 million.
For earnings history and earnings-related data on TrueBlue (TBI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- Flux Power Holdings, Inc. (FLUX) Misses Q1 EPS by 3c
- InnovAge (INNV) Tops Q1 EPS by 6c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share